We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+6.82%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$382M
AUM Growth
+$10.6M
Cap. Flow
-$9.98M
Cap. Flow %
-2.61%
Top 10 Hldgs %
41.14%
Holding
57
New
3
Increased
16
Reduced
26
Closed
2

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$8.37M
2
RTX icon
RTX Corp
RTX
+$3.76M
3
FISV
Fiserv Inc
FISV
+$1.99M
4
BDX icon
Becton Dickinson
BDX
+$1.64M
5
MDT icon
Medtronic
MDT
+$1.13M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$8.17M
2
ZBRA icon
Zebra Technologies
ZBRA
+$3.25M
3
VMW
VMware, Inc
VMW
+$2.99M
4
CDW icon
CDW
CDW
+$2.79M
5
ALSN icon
Allison Transmission
ALSN
+$1.18M

Sector Composition

Rank Sector Weight
1 Technology 25.99%
2 Healthcare 21.46%
3 Financials 14.46%
4 Consumer Staples 11.57%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMXI icon
51
International Money Express
IMXI
$394M
$378K 0.1%
15,419
XOM icon
52
ExxonMobil
XOM
$651B
$341K 0.09%
3,183
SPNS
53
DELISTED
Sapiens International
SPNS
$328K 0.09%
+12,325
New +$291K
NSP icon
54
Insperity
NSP
$2.06B
$327K 0.09%
2,747
INMD icon
55
InMode
INMD
$868M
$232K 0.06%
+6,204
New +$217K
ALLE icon
56
Allegion
ALLE
$13.4B
-2,154
Closed -$230K

Similar funds

Foyston, Gordon, & Payne's Q2 2023 Portfolio in Review

As of Q2 2023, Foyston, Gordon, & Payne held 57 positions worth $382M, up 2.8% from $372M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foyston, Gordon, & Payne's Q2 2023 filing shows 3 new, 16 increased, 26 reduced and 2 closed positions. Its largest new stake was RTX Corp: 38,368 shares worth $3.76M. The largest sale was Visa, an estimated $8.17M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne's largest Q2 2023 buy was RTX Corp: 38,368 shares worth $3.76M.
  • Foyston, Gordon, & Payne added most to Novartis in Q2 2023, an estimated $8.37M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2023 reduction was Visa, cutting an estimated $8.17M.
  • Foyston, Gordon, & Payne fully exited Allegion in Q2 2023, selling an estimated $230K.
  • Foyston, Gordon, & Payne's ten largest holdings make up 41% of its $382M portfolio in Q2 2023.
  • Foyston, Gordon, & Payne opened 3 new positions and closed 2 in Q2 2023.
  • Foyston, Gordon, & Payne's portfolio value rose 2.8% quarter-over-quarter to $382M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2023, filed 1 Aug 2023.